Affinity Asset Advisors, LLC Aslan Pharmaceuticals LTD Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$1.11 - $1.86 $277,500 - $465,000
-250,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$1.78 - $3.41 $445,000 - $852,500
250,000 New
250,000 $445,000
Q2 2021

Aug 13, 2021
SELL
$2.5 - $3.72 $500,000 - $744,000
-200,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$1.86 - $5.25 $372,000 - $1.05 Million
200,000 New
200,000 $670,000

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ASLAN Pharmaceuticals Ltd

ASLN Quotes by TradingView
  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email